SciDev.Net

Researchers are putting women's lives at risk by being too cautious about trialling drugs during pregnancy, say Nicholas J. White and colleagues.

Non-communicable disease treatment has a lot to learn from tuberculosis control programmes, say Anthony D. Harries and colleagues.

Doruk Ozgediz and Robert Riviello make the case for devoting more resources to easily treated surgical conditions in Africa.

Public-private partnership organisations have failed to include African researchers on an equal basis, say T. J. Tucker and M. W. Makgoba.

African malaria research networks have helped scientists combat the disease, but they need more stable support and longer-term funding, says Thomas Egwang.

The UN programme for HIV/AIDS is out of touch with reality and hindering health capacity building, argues Roger England.

Hypertensive disease kills large numbers in developing countries, but efforts to tackle it are lacking, say Stephen MacMahon and colleagues.

Successful vaccination against the main causes of pneumonia will complicate care of remaining cases, say J. Anthony G. Scott and Mike English.

Elimination of blinding trachoma is entirely possible by 2020, says the New England Journal of Medicine.

Malaria policy needs to be changed if WHO targets are to be met, warn Ephantus J. Muturi, Peter Burgess and Robert J. Novak.

Weaknesses in HIV research design have hindered progress in identifying prevention strategies, say Stephen W. Lagakos and Alicia R. Gable.

Peter J. Hotez believes the establishment of a new financing mechanism is vital for the control and eradication of neglected diseases.

Amy C. Morrison and colleagues outline key preventative measures for controlling the Aedes aegypti mosquito that spreads disease.

With the worldwide growth of resistance, new antibiotics are increasingly needed. But R&D can be expensive and time-consuming, says James Love.

Reducing antibiotic use is not enough to curb the rise of resistance in the developing world, say Zulfiqar A. Bhutta and Syed Rehan Ali.

Tackling antibiotic resistance requires well-run diagnostic laboratories, says Pradeep Seth.

Africa and India are struggling in the fight against tuberculosis, say Richard E. Chaisson, Neil A. Martinson and Vikram Paralkar.

Greg W. Fegan and Trudie A. Lang urge the use of open-source database systems to increase the scope and variety of clinical trials.

Mark Grabowsky argues that the billions of dollars invested in the fight against malaria are wasted without systematic disease surveillance.

Peter J. Hotez argues that the Guantanamo camp should be converted into a research institute for Latin America's neglected diseases.